Brief: Petros Pharmaceuticals Partners With Leading Global Contract Manufacturer
24/01/2022 14:42
Jan 24 (Reuters) - Petros Pharmaceuticals Inc PTPI.O :
* PETROS PHARMACEUTICALS PARTNERS WITH LEADING GLOBAL
CONTRACT
MANUFACTURER TO BRING PRODUCTION OF ERECTILE DYSFUNCTION DRUG
STENDRAÒ (AVANAFIL) TO THE UNITED STATES
* PETROS PHARMACEUTICALS INC - NEW PARTNERSHIP WILL TRANSFER
MANUFACTURING OF STENDRAO TO U.S.
* PETROS PHARMACEUTICALS INC - NEW PARTNERSHIP IS EXPECTED
TO
PROVIDE BOTH COST SAVINGS AND INCREASE IN GROSS MARGIN
Source text for Eikon: ID:nPn6TD6Wfa
Further company coverage: PTPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Petros Pharmaceuticals
See all newsBrief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
Brief: Petros Pharmaceuticals’ STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Brief: Petros Pharmaceuticals Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Brief: Petros Pharma Announces Partnership with Idea Evolver for Rx-to-OTC Switches & Digital Launch Solutions